MISSISSAUGA, Ontario, and ZUG, Switzerland, Feb. 1, 2011 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) and PharmaSwiss S.A. announced today that they have signed a binding agreement for Valeant to acquire PharmaSwiss, a privately-owned branded generics and over-t
Read the full article at PR Newswire: Health

